Autoria(s):
Pérez-Ruiz, Mercedes; Navarro-Marí, José-María; Sánchez-Seco, María-Paz; Gegúndez, María-Isabel; Palacios, Gustavo; Savji, Nazir; Lipkin, W Ian; Fedele, Giovanni; Ory-Manchón, Fernando de
Data(s)
15/02/2013
15/02/2013
01/05/2012
Resumo
Lymphocytic choriomeningitis virus (LCMV) was detected in 2 patients with acute meningitis in southern Spain within a 3-year period. Although the prevalence of LCMV infection was low (2 [1.3%] of 159 meningitis patients), it represents 2.9% of all pathogens detected. LCMV is a noteworthy agent of neurologic illness in immunocompetent persons.
Case Reports; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.;
his work was financed in part by Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (PI07/90154).
The research at the Center for Infection and Immunity was performed under the auspices of AI57158 (Northeast Biodefense Center-Lipkin), US Agency for International Development PREDICT program, and USA Defense Threat Reduction Agency
Identificador
Pérez-Ruiz M, Navarro-Marí JM, Sánchez-Seco MP, Gegúndez MI, Palacios G, Savji N, et al. Lymphocytic choriomeningitis virus-associated meningitis, southern Spain. Emerging Infect. Dis.. 2012 ; 18(5):855-8
